Device and method for intradermal cell implantation

• US 20050049625A1
• Filed: 08/24/2004
• Published: 03/03/2005
• Est. Priority Date: 08/26/2003
• Status: Abandoned Application

• Current Assignee: ALZA Corporation (Johnson & Johnson)
• Original Assignee: ALZA Corporation (Johnson & Johnson)
• Inventors: Daddona, Peter, Shaya, Steven
• Application Number:
  US10/925,518
• Publication Number:
  US 20050049625A1
• Time in Patent Office: Days
• US Class Current: 606/187
• CPC Class Codes: A61K 9/0021 Intradermal administration, e.g. through microneedle arrays, needleless injectors mechanical aspects A61M
• CPC Class Codes: A61M 2037/003 having a lumen
• CPC Class Codes: A61M 2037/0038 having a channel at the side surface
• CPC Class Codes: A61M 37/0015 by using microneedles
• CPC Class Codes: A61P 17/14 for baldness or alopecia

Abstract

The present invention relates to a device and method for implanting hair follicle-inducing cells within the scalp. The hair follicle cells are generated by the use of tissue culture process from autologous donor cells. The cells are placed upon a microprojection array for implantation within the scalp utilizing predetermined parameters of angle, density and depth.

Claims

1. A transdermal delivery system for implanting hair follicles in a patient comprising a microprojection array having a plurality of stratum corneum-piercing microprojections and a formulation of hair-follicle inducing cells deposited on at least one of said microprojections.

2. The transdermal delivery system of claim 1, wherein said at least one microprojection has a cavity and said formulation of hair-follicle inducing cells is deposited within said cavity.

3. The transdermal delivery system of claim 2, wherein said hair-follicle inducing cells comprise dermal papilla cells cultured from the group consisting of autologous, allogeneic, and xenogeneic primary sources.

4. The transdermal delivery system of claim 2, wherein said cavity has a symmetrical concave configuration.

5. The transdermal delivery system of claim 2, wherein said cavity further comprises a retention barrier.

6. The transdermal delivery system of claim 5, wherein said retention barrier is configured to substantially retain said deposited formulation upon insertion of said microprojection into tissue and to release said deposited formulation upon withdrawal of said microprojection from tissue.

7. The transdermal delivery system of claim 6, wherein said cavity further comprises a sloped leading edge configured to facilitate release of said deposited formulation upon withdrawal of said microprojection from tissue.

8. The transdermal delivery system of claim 2, wherein said at least one microprojection has a broad surface and a narrow edge.

9. The transdermal delivery system of claim 8, wherein said cavity is positioned on said broad surface.

10. The transdermal delivery system of claim 9, wherein said cavity is positioned on said narrow edge.

11. The transdermal delivery system of claim 10, wherein said at least one microprojection further comprises a pressure conduit configured to communicate pressure to said cavity to facilitate dislodging said deposited formulation.

12. The transdermal delivery system of claim 10, wherein said cavity further comprises a retention pocket that is configured to substantially retain said deposited formulation upon insertion of said microprojection into tissue and to release said deposited formulation upon withdrawal of said microprojection from tissue.

13. The transdermal delivery system of claim 2, wherein said cavity is configured to substantially retain said deposited formulation upon insertion of said microprojection into tissue.

14. The transdermal delivery system of claim 1, wherein said at least one microprojection has an absolute orientation configured to produce a desired wound path.

15. The transdermal delivery system of claim 14, wherein said delivery system further comprises a sheet from which said at least one microprojection protrudes and said absolute orientation comprises an angle of said at least one microprojection with respect to said sheet.

16. The transdermal delivery system of claim 14, wherein said absolute orientation is configured to result in a desired hair follicle orientation.

17. The transdermal delivery system of claim 15, wherein said angle is between about 45 degrees and 90 degrees.

18. The transdermal delivery system of claim 2, wherein said at least one microprojection has a hydrophobic coating except on said cavity and wherein said formulation is aqueous.

19. The transdermal delivery system of claim 1, wherein said formulation is frozen.

20. The transdermal delivery system of claim 1, further comprising a bioerodible polymer applied to said at least one microprojection and wherein said formulation is incorporated within said bioerodible polymer.

21. The transdermal delivery system of claim 1, wherein said formulation comprises an autologous tissue culture of dermal papilla cells.

22. The transdermal delivery system of claim 1, wherein said formulation is selected from the group consisting of allogeneic cells and xenogeneic cells.

24. The method of claim 22, wherein said step of applying said microprojection array comprises inserting said at least one microprojection through said stratum corneum so that a substantial portion of said formulation remains deposited on said microprojection.

26. The method of claim 22, further comprising the step of freezing the formulation on said at least one microprojection and wherein the step of delivering said formulation comprises allowing said formulation to thaw after said at least one microprojection pierces the stratum corneum.

27. The method of claim 22, wherein said microprojection array further comprises a bioerodible polymer applied to said at least one microprojection and wherein said formulation is incorporated within said bioerodible polymer and wherein said step of delivering said formulation comprises allowing said bioerodible polymer to dissolve within tissue below the stratum corneum.

28. The method of claim 22, further comprising the step of selecting an absolute orientation and a relative orientation of said at least one microprojection to create a desired wound path.

29. The method of claim 27, further comprising the step of influencing hair follicle orientation by creating said desired wound path.

23. A method for treating hair loss in a patient, comprising the steps of:

providing a microprojection array having a plurality of stratum corneum-piercing microprojections and a formulation of hair-follicle inducing cells deposited on at least one of said microprojections;

applying said microprojection array to said patient so that said at least one microprojection pierces the stratum corneum of said patient; and

delivering said formulation of hair-follicle inducing cells to tissue beneath the stratum corneum.

25. The method of claim 23, wherein the step of delivering said formulation comprises withdrawing said at least one microprojection so that a substantial portion of said formulation remains in tissue beneath the stratum corneum.

30. A method for growing hair on a patient comprising the step of transdermally implanting hair follicle-inducing cells with a microprojection array.

32. The method of claim 30, wherein said step of providing a microprojection array comprises providing an array having at least one microprojection with a hydrophobic coating and a non-hydrophobic cavity and wherein said step of depositing said formulation comprises applying said formulation to said at least one microprojection whereby said formulation is retained on said non-hydrophobic cavity and not retained on said hydrophobic coating.

33. The method of claim 30, further including the step of freezing said deposited formulation after said formulation is deposited.

34. The method of claim 30, wherein the said of depositing said formulation on said at least one microprojection comprises applying a bioerodible polymer to said at least one microprojection and incorporating said formulation within said bioerodible polymer.

31. A method for forming a hair loss treatment device, comprising the steps of:

providing a microprojection array; and

depositing a formulation of hair follicle-inducing cells on said microprojection array.